Farther Finance Advisors’s Century Therapeutics IPSC Stock Holding History

Farther Finance Advisors’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,500	Closed	-$5.47K	–	6050
2026 Q1	$5.47K	Buy	+2,500	New	+$5.26K	﹤0.01%	4442

Other funds holding IPSC

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors's IPSC Position: Q2 2026 in Review

Farther Finance Advisors sold out of Century Therapeutics (IPSC) in Q2 2026, closing a stake of 2,500 shares — an estimated $5.47K sold.

Farther Finance Advisors first reported a position in IPSC in Q1 2026 and held it in 1 quarter. The position peaked at $5.47K in Q1 2026. 4 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Farther Finance Advisors reported no remaining Century Therapeutics position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 2,500 Century Therapeutics shares in Q2 2026, an estimated $5.47K.
Farther Finance Advisors first reported a position in Century Therapeutics in Q1 2026 and held it in 1 quarter.
Farther Finance Advisors's Century Therapeutics position peaked at $5.47K in Q1 2026.
4 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.